“$192 million in new projects that will be prioritized under the new Strategic Innovation Fund COVIDcampaign-pages/bispecifics/-19 stream to deliver direct support to Canadian companies for large-scale projects. These companies include… AbCellera, a Vancouver-based biotech company that has built the world’s leading technology for antibody discovery, is at the forefront of developing antibody-based drugs to treat and prevent COVIDcampaign-pages/bispecifics/-19.”
Read full coverage on Justin Trudeau, Prime Minister of Canada News.